*Currently Accepting Participants*
*This page is for general information only. If you are interested in participating in this study, please visit the SYMBA study website for more information.*
Study short name: SYMBA
Study full name: Dietary modulation of maternal gut flora with oligosaccharides in pregnancy as a novel allergy prevention strategy
Principle Investigator: Susan Prescott
Administering Institute: Telethon Kids Institute
Major funding source: National Health and Medical Research Council (NHMRC)
Study focus: Prevention
Study design: Intervention
Main study aim: To determine whether maternal prebiotic supplementation during pregnancy and breastfeeding can reduce the development of eczema in babies.
Additional study information: Prebiotics are a type of fibre that occur naturally in foods such as whole grains, vegetables and legumes. They are called ‘prebiotics’ because they are digested by gut bacteria, but are different from ‘probiotics’ which are the actual ‘friendly bacteria’. Participating women will be asked to consume a prebiotic or placebo powder daily, from mid-pregnancy until their baby is 6 months old.
Study population: Pregnant women, less than 21 weeks gestation, whose baby-to-be has a mother, father or sibling with a history of medically diagnosed allergic disease (asthma, allergic rhinitis, eczema and/or food allergy).
Study status: Recruitment ongoing, through March 2021.
Where can I find more information?
Australia New Zealand Clinical Trials Registry: https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12615001075572
Study contact: [email protected]
Last modified: April 12th 2019 | Date created: April 9th 2019